Holistic Regulation of Angiogenesis with Chinese Herbal Medicines as a New Option for Coronary Artery Disease

about

Holistic Regulation of Angiogenesis with Chinese Herbal Medicines as a New Option for Coronary Artery Disease

Item

http://www.wikidata.org/entity/Q58784996

description

article

@en

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Holistic Regulation of Angioge ...... on for Coronary Artery Disease

@en

Holistic Regulation of Angioge ...... on for Coronary Artery Disease

@nl

type

Item

label

Holistic Regulation of Angioge ...... on for Coronary Artery Disease

@en

Holistic Regulation of Angioge ...... on for Coronary Artery Disease

@nl

prefLabel

Holistic Regulation of Angioge ...... on for Coronary Artery Disease

@en

Holistic Regulation of Angioge ...... on for Coronary Artery Disease

@nl

P1476

Holistic Regulation of Angioge ...... on for Coronary Artery Disease

@en

P2093

Qi-Qi Xin

http://www.w3.org/2001/XMLSchema#string

Wei-Li Shi

http://www.w3.org/2001/XMLSchema#string

P2860

Tongxinluo mitigates atherogenesis by regulating angiogenic factors and inhibiting vasa vasorum neovascularization in apolipoprotein E-deficient mice

VEGF receptor signalling - in control of vascular function

Angiogenic factors

Normalization of the vasculature for treatment of cancer and other diseases.

Calycosin promotes angiogenesis involving estrogen receptor and mitogen-activated protein kinase (MAPK) signaling pathway in zebrafish and HUVEC

VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial

The Role of NOX4 and TRX2 in Angiogenesis and Their Potential Cross-Talk.

Plaque angiogenesis and atherosclerosis.

Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association.

Janus phenomenon: the interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis.

P304

3725962

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/3725962

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Rong Yuan

Weihong Cong

Keji Chen

P577

2018-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30186354

http://www.w3.org/2001/XMLSchema#string

P932

6110048

http://www.w3.org/2001/XMLSchema#string